Help us improve guidance content on our website. Complete our short survey.
Filter results
You can narrow down the results using the filters
Topic
- Advertising (215)
- COVID-19 (118)
- Medicines safety (98)
- Prescription medicines (72)
- COVID-19 vaccines (71)
- Regulatory compliance (70)
- Legislation (62)
- Medicines (61)
- Medical devices safety (36)
- Listed medicines (33)
- Medical devices (33)
- Non-prescription medicines (28)
- Therapeutic goods regulation (26)
- Manufacturing (23)
- Complementary medicines (22)
- Assessed listed medicines (21)
- Scheduling (national classification system) (21)
- Unapproved therapeutic goods (18)
- Labelling and packaging (16)
- Safety (15)
- Medicinal cannabis hub (11)
- Nicotine vaping products hub (10)
- Over the counter medicine (10)
- Shortages (10)
- Australian Register of Therapeutic Goods (ARTG) (8)
- Import and export (8)
- Sunscreens (8)
- In Vitro Diagnostic medical devices (IVDs) (7)
- Alert/Advisory (4)
- Advisory bodies and committees (3)
- Compliance and enforcement hub (3)
- Other therapeutic goods (3)
- Biologicals (2)
- Fees and payments (2)
- Weight loss products (2)
- Biological medicines (1)
- Blood and blood components (1)
- Blood safety (1)
- Clinical trials (1)
- Cosmetics (1)
- Prescription opioids hub (1)
- Travelling with health products (1)
- Unique Device Identification (UDI) Hub (1)
Search
910 result(s) found, displaying 1 to 25
- Media releasesAffinity Corp Australia Pty Ltd fined $66,600 for alleged unlawful advertising of medicinal cannabis productsThe TGA has issued 5 infringement notices to Affinity Corp Australia Pty Ltd for the alleged unlawful advertising of medicinal cannabis products.
- BlogDo you read the label every time?Check the labels of all medicines and medical devices, including those you buy without a doctor’s prescription.
- Safety updatesProduct Information safety updates - April and May 2023Medicines Safety Update - Information for health professionals
- NewsTGA supports MHRA’s new international recognition framework for medicinesThese international recognition routes, which have been facilitated by existing international partnerships such as those developed through the Access Consortium and Project Orbis, are part of a new international recognition framework for medicines that is specific to the UK following their exit from the European Union.
- Media releases2023 Seasonal Influenza VaccinesInfluenza vaccines can change from year to year as new strains of influenza virus appear. This is one reason vaccination against influenza is given every year.
- COVID-19 vaccine safety reportsCOVID-19 vaccine safety report - 01-06-2023Information about the TGA's safety monitoring of COVID-19 vaccines.
- BlogHow to find out what’s in your medicineWant to know what’s in your medicines? The obvious place to start is with the medicine’s label, but there may be more to it.
- Safety updatesOral anticoagulants can cause serious kidney damage in rare circumstancesA warning about anticoagulant-related nephropathy (ARN) has been added to the Product Information (PI) for all oral anticoagulants.
- NewsLifeblood sexual activity and PrEP deferralsThe TGA has approved applications submitted by Australian Red Cross Lifeblood (Lifeblood) to remove most of the sexual activity ineligibility criteria for plasma donors used for fractionated products only. Lifeblood refers to this approach as ‘the plasma pathway’.
- NewsPhase out of ISO 13485 certificates for IVD medical devicesTransition period for accepting ISO 13485 ends 26 May 2023.
- Media releasesQueensland individual fined nearly $16,000 after allegedly importing unregistered nicotine vaping productsIt is alleged that the individual attempted to import six different types of nicotine vaping products (prescription medicines). The unapproved nicotine vaping products were intercepted by the Australian Border Force and have been seized and will be destroyed under advice from the TGA.
- NoticesTherapeutic Goods (Adverse Event Management System - Sponsors) (Arrangement for Computer Programs) Instrument 2023Arrangement under subsection 7C(1) of the Therapeutic Goods Act 1989
- NoticesInstrument of arrangement: Use of computer program to make decisions, July 2018Arrangement under subsection 7C(1) of the Therapeutic Goods Act 1989
- COVID-19 vaccine safety reportsCOVID-19 vaccine weekly safety report - 18-05-2023Information about the TGA's safety monitoring of COVID-19 vaccines.
- NoticesGMP Clearance: Extension processing timesDelays in processing timeframes of applications to extend GMP Clearances.
- NewsUpdates to the Prescribing Medicines in Pregnancy database, May 2023The Prescribing Medicines in Pregnancy database has now been updated.
- Media releasesTGA targets unlawful importation of prescription medicinesThe TGA has issued 5 infringement notices to 3 health practitioners for the alleged unlawful importation of unregistered prescription-only medicines.
- Safety updatesImportant safety information for Janus kinase (JAK) inhibitorsNew warnings for baricitinib, tofacitinib and upadacitinib follow a TGA review of a randomised safety trial called the ORAL Surveillance Study.
- NewsTGA publishes updated guidelines for sunscreensThe TGA has updated the Australian Regulatory Guidelines for Sunscreens (ARGS) to align with the data requirements for all ingredients proposed to be included in the Therapeutic Goods (Permissible Ingredients) Determination
- NewsPatient implant cards and information leafletsAn overview of the information that will be provided in patient information leaflets and patient implant cards for permanently implantable medical devices
- NewsEU MDR transition extensionThe TGA will recognise the extended transition for the European Union Medical Device Regulation (EU MDR).
- COVID-19 vaccine safety reportsCOVID-19 vaccine safety report - 04-05-23Information about the TGA's safety monitoring of COVID-19 vaccines.
- Safety updatesLive vaccines – what are the contraindications?Medicines Safety Update - Information for health professionals
- Media releasesRemoval of prescribing restrictions on ivermectinFrom 1 June 2023, prescribing of oral ivermectin for ‘off-label’ uses will no longer be limited to specialists such as dermatologists, gastroenterologists and infectious diseases specialists.
- Media releasesTGA makes final decision to reduce paracetamol pack sizesThe TGA has published a final decision to reduce the maximum size of packs for various paracetamol products.
Pages
- Current page 1
- Page 2
- Page 3
- Page 4
- Page 5
- Page 6
- Page 7
- Page 8
- Page 9
- …
- Next page Next ›
- Last page Last »